Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 7—July 2021
Dispatch

Polymicrobial Infections Among Patients with Vascular Q Fever, France, 2004–2020

Mathilde PugesComments to Author , Xavier Bérard, Caroline Caradu, Maïlys Ducours, Carole Eldin, Mathilde Carrer, Noémie Sauvage, Marc-Olivier Vareil, Laure Alleman, Fatima M’Zali, Sabine Pereyre, and Charles Cazanave
Author affiliations: Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France (M. Puges, X. Bérard, C. Caradu, M. Ducours, M. Carrer, N. Sauvage, S. Pereyre, C. Cazanave); IHU-Méditerranée Infection, Marseille, France (C. Eldin); Aix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille (C. Eldin); Centre Hospitalier de la Côte Basque, Bayonne, France (M.-O. Vareil, L. Alleman); University of Bordeaux, Bordeaux (F. M’Zali, S. Pereyre, C. Cazanave)

Main Article

Table 2

Serologic assay results of patients with vascular Q fever complicated by polymicrobial infections, France, 2014–2020*

Serologic results, time of assay† Patient (month of Q fever diagnosis)
1 (2015 Apr) 2 (2020 Jun) 3 (2015 Jul) 4 (2019 Sep) 5 (2010 Dec)
Before Q fever diagnosis
 NA
 NA
 NA
 NA
 2007 Aug 9: 1,600/0/0–3,200/0/0; 2007 Aug 29: 1,600/0/0–3,200/0/0; 2007 Nov: 1,600/0/0–3,200/0/0; 2008 May: 800/0/0–1,600/0/0
At Q fever diagnosis
 2015 Apr: 800/0/200–100/0/0
 2020 Jun 15: 100/0/0–100/0/0; 2020 Jun 17: 100/0/0–100/0/0
 Borderline
 2019 Sep: 1,600/0/800–1,600/0/800
 2010 Dec: 400/0/100–800/0/200
After Q fever diagnosis 2015 Jul: 800/0/200–400/0/0; 2016 Aug: 800/0/400–200/0/0; 2017 Dec: 400/0/200–200/0/100 NA‡ NA NA‡ NA‡

*NA, not available. †Values are titers against C. burnetti phase I–phase II (IgG/IgM/IgA). ‡Values NA because of patient death: patient 2 died on day 37, patient 4 died on day 27, and patient 5 died on day 12.

Main Article

Page created: April 21, 2021
Page updated: June 17, 2021
Page reviewed: June 17, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external